Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

England C diff dip "inaccurate" MRSA plateau "no cause for alarm":

This article was originally published in Clinica

Executive Summary

Provisional UK data on methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile healthcare-associated bloodstream infections in the last quarter of 2007 show a 0.6% increase and 8% fall, respectively, on the previous quarter. The HPA has dismissed the "plateau" in reducing the incidence of MRSA in England - 1,087 compared with 1,080 during July-September - as falling within reasonable limits and "no cause for alarm". Of the C diff figures - 9,872 (from 10,751) cases aged over 64 years and 2,211 (from 2,507) in the 2-64 age range - the agency acknowledged that they are probably inaccurate, as the data were collected during the transition of refinements to the reporting system. The next quarterly figures, due to be published in July, should prove more meaningful; the HPA is also scheduled to publish final annual statistics for 2007.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT046875

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel